Skip to main content
logo
Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · Real-Time Price · USD
32.18
-0.23 (-0.71%)
Oct 1, 2026, 3:08 PM EDT - Market open

Celldex Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2,5271,8051,6772,1692,0991,803
Market Cap Growth
45.30%7.65%-22.71%3.32%16.42%160.10%
Enterprise Value
1,8141,2249241,9361,7791,383
Last Close Price
32.4127.1625.2739.6644.5738.64

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
16043.881168.13238.82315.12890.64387.68
PB Ratio
3.563.422.245.056.444.30
P/TBV Ratio
3.693.612.335.407.024.60

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
11533.23792.34131.57281.34754.94297.37

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.000.010.010.010.01
Net Debt / Equity Ratio
-1.00-0.98-0.97-0.98-0.92-0.97
Net Debt / EBITDA Ratio
2.211.823.763.032.896.13
Net Debt / FCF Ratio
2.942.424.523.862.856.52
Asset Turnover
00.000.010.020.010.01
Quick Ratio
11.7110.2118.3813.6916.4124.71
Current Ratio
11.8210.4918.9213.8717.0724.86
Return on Equity (ROE)
-43.88%-40.62%-26.84%-37.45%-30.13%-22.43%
Return on Assets (ROA)
-27.62%-26.12%-19.38%-21.70%-16.79%-12.70%
Return on Capital Employed (ROCE)
-45.20%-54.00%-25.90%-32.70%-32.10%-16.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-11.86%-14.34%-9.42%-6.52%-5.35%-3.91%
FCF Yield
-9.55%-11.84%-9.53%-5.03%-5.03%-3.45%
Buyback Yield / Dilution
-4.49%-3.15%-32.91%-3.33%-9.37%-44.64%
SEC Filings: 10-K · 10-Q